{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T23:40:29Z","timestamp":1780616429010,"version":"3.54.1"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T00:00:00Z","timestamp":1582675200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["16H05441"],"award-info":[{"award-number":["16H05441"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["18K09001"],"award-info":[{"award-number":["18K09001"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0229577","type":"journal-article","created":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T18:31:50Z","timestamp":1582741910000},"page":"e0229577","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":21,"title":["miR-101, miR-548b, miR-554, and miR-1202 are reliable prognosis predictors of the miRNAs associated with cancer immunity in primary central nervous system lymphoma"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8876-6673","authenticated-orcid":true,"given":"Yasuo","family":"Takashima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Iwadate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Hondoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7103-8493","authenticated-orcid":true,"given":"Junya","family":"Fukai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Kajiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azusa","family":"Hayano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2941-7996","authenticated-orcid":true,"given":"Ryuya","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,2,26]]},"reference":[{"issue":"6","key":"pone.0229577.ref001","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary","volume":"131","author":"DN Louis","year":"2016","journal-title":"Acta Neuropathol"},{"issue":"9830","key":"pone.0229577.ref002","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/S0140-6736(11)61346-9","article-title":"Primary brain tumours in adults","volume":"379","author":"D Ricard","year":"2012","journal-title":"Lancet"},{"issue":"2","key":"pone.0229577.ref003","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11060-014-1379-4","article-title":"Non-deep-seated primary CNS lymphoma: therapeutic responses and a molecular signature","volume":"117","author":"Y Iwadate","year":"2014","journal-title":"J Neurooncol"},{"key":"pone.0229577.ref004","first-page":"175","article-title":"Salvage Therapy for Primary Central Nervous System Lymphoma. In: Yamanaka R (ed). Primary Central Nervous System Lymphoma (PCNSL): Incidence, Management and Outcomes","author":"R Yamanaka","year":"2016","journal-title":"Nova Science Publishers (NY)"},{"issue":"1","key":"pone.0229577.ref005","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrclinonc.2015.187","article-title":"Novel immunotherapies in lymphoid malignancies","volume":"13","author":"CL Batlevi","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"issue":"7","key":"pone.0229577.ref006","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1182\/blood-2018-01-791558","article-title":"Novel agents for primary central nervous system lymphoma: evidence and perspectives","volume":"132","author":"G Illerhaus","year":"2018","journal-title":"Blood"},{"issue":"20","key":"pone.0229577.ref007","doi-asserted-by":"crossref","first-page":"6446","DOI":"10.1158\/1078-0432.CCR-09-1339","article-title":"Phase I study of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with relapsed and refractory B-cell non-Hodgkin lymphoma","volume":"15","author":"SM Ansell","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"1","key":"pone.0229577.ref008","doi-asserted-by":"crossref","first-page":"42","DOI":"10.5414\/NP300698","article-title":"PD1 (CD279) and PD-L1 (CD274, B7H1) expression in primary central nervous system lymphomas (PCNSL)","volume":"33","author":"AS Berghoff","year":"2014","journal-title":"Clin Neuropathol"},{"issue":"4","key":"pone.0229577.ref009","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1411087","article-title":"PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma","volume":"372","author":"SM Ansell","year":"2015","journal-title":"N Engl J Med"},{"issue":"50","key":"pone.0229577.ref010","doi-asserted-by":"crossref","first-page":"87317","DOI":"10.18632\/oncotarget.20264","article-title":"Programmed cell death 1 expression is associated with inferior survival in patients with primary central nervous system lymphoma","volume":"8","author":"H Cho","year":"2017","journal-title":"Oncotarget"},{"issue":"23","key":"pone.0229577.ref011","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1182\/blood-2017-01-764209","article-title":"PD-1 blockade with nivolumab in relapsed\/refractory primary central nervous system and testicular lymphoma","volume":"129","author":"L Nayak","year":"2017","journal-title":"Blood"},{"issue":"10","key":"pone.0229577.ref012","first-page":"5655","article-title":"Programmed Cell Death Ligand 1 Expression in Primary Central Nervous System Lymphomas: A Clinicopathological Study","volume":"37","author":"A Hayano","year":"2017","journal-title":"Anticancer Res"},{"issue":"1","key":"pone.0229577.ref013","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3960\/jslrt.17006","article-title":"Stat3 inhibitor abrogates the expression of PD-1 ligands on lymphoma cell lines","volume":"57","author":"C Ma","year":"2017","journal-title":"J Clin Exp Hematop"},{"issue":"2","key":"pone.0229577.ref014","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3960\/jslrt.18001","article-title":"The expression of PD-1 ligands and IDO1 by macrophage\/microglia in primary central nervous system lymphoma","volume":"58","author":"Y Miyasato","year":"2018","journal-title":"J Clin Exp Hematop"},{"issue":"2","key":"pone.0229577.ref015","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0092-8674(00)81644-X","article-title":"The rde-1 gene, RNA interference, and transposon silencing in C. elegans","volume":"99","author":"H Tabara","year":"1999","journal-title":"Cell"},{"issue":"1","key":"pone.0229577.ref016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.117.242636","article-title":"MicroRNA-Directed Cancer Therapies: Implications in Melanoma Intervention","volume":"364","author":"A Thyagarajan","year":"2018","journal-title":"J Pharmacol Exp Ther"},{"issue":"19","key":"pone.0229577.ref017","doi-asserted-by":"crossref","first-page":"R772","DOI":"10.1016\/S0960-9822(01)00467-5","article-title":"RNA interference: it's a small RNA world","volume":"11","author":"EG Moss","year":"2001","journal-title":"Curr Biol"},{"key":"pone.0229577.ref018","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/978-3-319-23730-5_2","article-title":"microRNA and Chronic Lymphocytic Leukemia","volume":"889","author":"DE Giza","year":"2015","journal-title":"Adv Exp Med Biol"},{"issue":"8","key":"pone.0229577.ref019","doi-asserted-by":"crossref","first-page":"5642","DOI":"10.1002\/jcp.26290","article-title":"Roles and clinical implications of microRNAs in acute lymphoblastic leukemia","volume":"233","author":"S Ultimo","year":"2018","journal-title":"J Cell Physiol"},{"issue":"12","key":"pone.0229577.ref020","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41408-017-0033-8","article-title":"MicroRNAs regulate key cell survival pathways and mediate chemosensitivity during progression of diffuse large B-cell lymphoma","volume":"7","author":"SK Leivonen","year":"2017","journal-title":"Blood Cancer J"},{"issue":"10","key":"pone.0229577.ref021","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1093\/neuonc\/nor107","article-title":"Differential micro-RNA expression in primary CNS and nodal diffuse large B-cell lymphomas","volume":"13","author":"L Fischer","year":"2011","journal-title":"Neuro Oncol"},{"key":"pone.0229577.ref022","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.leukres.2018.05.006","article-title":"Over expression of circulating miR-155 predicts prognosis in diffuse large B-cell lymphoma","volume":"70","author":"M Ahmadvand","year":"2018","journal-title":"Leuk Res"},{"key":"pone.0229577.ref023","first-page":"39","article-title":"MicroRNAs as biomarkers for CNS disease","volume":"6","author":"P Rao","year":"2013","journal-title":"Front Mol Neurosci"},{"issue":"3","key":"pone.0229577.ref024","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ejca.2014.10.028","article-title":"Differentially regulated miRNAs as prognostic biomarkers in the blood of primary CNS lymphoma patients","volume":"51","author":"P Roth","year":"2015","journal-title":"Eur J Cancer"},{"issue":"12","key":"pone.0229577.ref025","doi-asserted-by":"crossref","first-page":"29103","DOI":"10.3390\/ijms161226150","article-title":"Tumor-Associated CSF MicroRNAs for the Prediction and Evaluation of CNS Malignancies","volume":"16","author":"T Shalaby","year":"2015","journal-title":"Int J Mol Sci"},{"issue":"3","key":"pone.0229577.ref026","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1007\/s12035-014-8822-6","article-title":"MicroRNAs as Potential Biomarkers for Diagnosing Cancers of Central Nervous System: a Meta-analysis","volume":"51","author":"D Wei","year":"2015","journal-title":"Mol Neurobiol"},{"issue":"1","key":"pone.0229577.ref027","doi-asserted-by":"crossref","first-page":"e0210400","DOI":"10.1371\/journal.pone.0210400","article-title":"MicroRNA signature constituted of miR-30d, miR-93, and miR-181b is a promising prognostic marker in primary central nervous system lymphoma","volume":"14","author":"Y Takashima","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"pone.0229577.ref028","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/hep.28548","article-title":"Suppression of lethal-7b and miR-125a\/b Maturation by Lin28b Enables Maintenance of Stem Cell Properties in Hepatoblasts","volume":"64","author":"Y Takashima","year":"2016","journal-title":"Hepatology"},{"issue":"44","key":"pone.0229577.ref029","doi-asserted-by":"crossref","first-page":"27471","DOI":"10.18632\/oncotarget.25463","article-title":"Target amplicon exome-sequencing identifies promising diagnosis and prognostic markers involved in RTK-RAS and PI3K-AKT signaling as central oncopathways in primary central nervous system lymphoma","volume":"9","author":"Y Takashima","year":"2018","journal-title":"Oncotarget"},{"issue":"20","key":"pone.0229577.ref030","doi-asserted-by":"crossref","first-page":"5672","DOI":"10.1158\/1078-0432.CCR-12-0596","article-title":"Gene expression signature-based prognostic risk score in patients with primary central nervous system lymphoma","volume":"18","author":"A Kawaguchi","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"8","key":"pone.0229577.ref031","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/hepr.12192","article-title":"Serum albumin level is a notable profiling factor for non-B, non-C hepatitis virus-related hepatocellular carcinoma: A data-mining analysis","volume":"44","author":"S Yamada","year":"2014","journal-title":"Hepatol Res"},{"issue":"5","key":"pone.0229577.ref032","doi-asserted-by":"crossref","first-page":"e0216825","DOI":"10.1371\/journal.pone.0216825","article-title":"CD276 and the gene signature composed of GATA3 and LGALS3 enable prognosis prediction of glioblastoma multiforme","volume":"14","author":"Y Takashima","year":"2019","journal-title":"PLoS One"},{"issue":"27","key":"pone.0229577.ref033","doi-asserted-by":"crossref","first-page":"19065","DOI":"10.18632\/oncotarget.24897","article-title":"Correlation between lower balance of Th2 helper T-cells and expression of PD-L1\/PD-1 axis genes enables prognostic prediction in patients with glioblastoma","volume":"9","author":"Y Takashima","year":"2018","journal-title":"OncotargetApr 10"},{"key":"pone.0229577.ref034","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.2147\/CMAR.S197744","article-title":"miR-101 regulates cell proliferation and apoptosis by targeting KDM1A in diffuse large B cell lymphoma","volume":"11","author":"Y Huang","year":"2019","journal-title":"Cancer Manag Res"},{"issue":"1","key":"pone.0229577.ref035","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/cns.12321","article-title":"miR-101 acts as a tumor suppressor by targeting Kruppel-like factor 6 in glioblastoma stem cells","volume":"21","author":"YL Yao","year":"2015","journal-title":"CNS Neurosci Ther"},{"key":"pone.0229577.ref036","article-title":"miR-548b-3p functions as a tumor suppressor in lung cancer","author":"Z Wang","year":"2019","journal-title":"Lasers Med Sci"},{"issue":"3","key":"pone.0229577.ref037","first-page":"267","article-title":"The Association of miR-let 7b and miR-548 with","volume":"16","author":"M Saffari","year":"2019","journal-title":"PTEN in Prostate Cancer. Urol J"},{"key":"pone.0229577.ref038","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.biopha.2015.07.027","article-title":"MiR-548-3p functions as an anti-oncogenic regulator in breast cancer","volume":"75","author":"Y Shi","year":"2015","journal-title":"Biomed Pharmacother"},{"issue":"17","key":"pone.0229577.ref039","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1097\/WNR.0000000000000690","article-title":"miR-548b inhibits the proliferation and invasion of malignant gliomas by targeting metastasis tumor-associated protein-2","volume":"27","author":"Y Pan","year":"2016","journal-title":"Neuroreport"},{"issue":"3","key":"pone.0229577.ref040","first-page":"2332","article-title":"MicroRNA-548b inhibits proliferation and invasion of hepatocellular carcinoma cells by directly targeting specificity protein 1","volume":"18","author":"H Qiu","year":"2019","journal-title":"Exp Ther Med"},{"key":"pone.0229577.ref041","doi-asserted-by":"crossref","first-page":"5821","DOI":"10.2147\/CMAR.S198615","article-title":"microRNA-548b suppresses aggressive phenotypes of hepatocellular carcinoma by directly targeting high-mobility group box 1 mRNA","volume":"11","author":"Z Yun","year":"2019","journal-title":"Cancer Manag Res"},{"issue":"6","key":"pone.0229577.ref042","doi-asserted-by":"crossref","first-page":"881","DOI":"10.4149\/neo_2018_171206N803","article-title":"MicroRNA-548-3p and MicroRNA-576-5p enhance the migration and invasion of esophageal squamous cell carcinoma cells via NRIP1 down-regulation","volume":"65","author":"XF Ni","year":"2018","journal-title":"Neoplasma"},{"issue":"7","key":"pone.0229577.ref043","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/nm.3582","article-title":"miR-1202 is a primate-specific and brain-enriched microRNA involved in major depression and antidepressant treatment","volume":"20","author":"JP Lopez","year":"2014","journal-title":"Nat Med"},{"issue":"4","key":"pone.0229577.ref044","first-page":"1010428317697565","article-title":"MiR-1202 functions as a tumor suppressor in glioma cells by targeting Rab1","volume":"39","author":"Y Quan","year":"2017","journal-title":"A. Tumour Biol"},{"key":"pone.0229577.ref045","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.biopha.2017.11.090","article-title":"MiR-1202 suppresses hepatocellular carcinoma cells migration and invasion by targeting cyclin dependent kinase 14","volume":"96","author":"B Du","year":"2017","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"pone.0229577.ref046","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.3892\/or.2017.5596","article-title":"Exploration of miR-1202 and miR-196a in human endometrial cancer based on high throughout gene screening analysis","volume":"37","author":"H Chen","year":"2017","journal-title":"Oncol Rep"},{"issue":"3","key":"pone.0229577.ref047","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s11060-018-2749-0","article-title":"MicroRNA-30c as a novel diagnostic biomarker for primary and secondary B-cell lymphoma of the CNS","volume":"137","author":"A Baraniskin","year":"2018","journal-title":"J Neurooncol"},{"issue":"11","key":"pone.0229577.ref048","doi-asserted-by":"crossref","first-page":"e0187722","DOI":"10.1371\/journal.pone.0187722","article-title":"Plasma microRNA profiling: Exploring better biomarkers for lymphoma surveillance","volume":"12","author":"D Khare","year":"2017","journal-title":"PLoS One"},{"issue":"49","key":"pone.0229577.ref049","doi-asserted-by":"crossref","first-page":"86020","DOI":"10.18632\/oncotarget.20902","article-title":"MicroRNAs as predictors for CNS relapse of systemic diffuse large B-cell lymphoma","volume":"8","author":"N Pillar","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"pone.0229577.ref050","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1365-2141.2008.07237.x","article-title":"MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas","volume":"142","author":"A Roehle","year":"2008","journal-title":"Br J Haematol"},{"issue":"3","key":"pone.0229577.ref051","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/jcp.22899","article-title":"Post-transcriptional regulation of the Ras-ERK\/MAPK signaling pathway","volume":"227","author":"JT Whelan","year":"2012","journal-title":"J Cell Physiol"},{"issue":"4","key":"pone.0229577.ref052","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00277-011-1350-9","article-title":"Serum microRNAs are promising novel biomarkers for diffuse large B cell lymphoma","volume":"91","author":"C Fang","year":"2012","journal-title":"Ann Hematol"},{"issue":"4","key":"pone.0229577.ref053","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy","volume":"168","author":"P Sharma","year":"2017","journal-title":"Cell"},{"issue":"11","key":"pone.0229577.ref054","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1111\/cas.13798","article-title":"Prolonged inhibition of hepatocellular carcinoma cell proliferation by combinatorial expression of defined transcription factors","volume":"109","author":"Y Takashima","year":"2018","journal-title":"Cancer Sci"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0229577","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T03:09:29Z","timestamp":1614568169000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0229577"}},"subtitle":[],"editor":[{"given":"Hiroyoshi","family":"Ariga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,2,26]]},"references-count":54,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,2,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0229577","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,26]]}}}